抑制ErbB2可以缓解创伤性肌肉损伤后的二次变质
Jacob R Sorensen1, Daniel B Hoffman1, Christiana J Raymond-Pope1
1School of Kinesiology, University of Minnesota, Minneapolis, Minnesota, USA.
The Journal of physiology
|March 4, 2025
概括
在体积肌肉损失 (VML) 损伤后药理上抑制ErbB2信号传递,改善了神经再生和肌肉内置. 然而,这并没有转化为功能恢复,这表明需要进一步研究VML治疗.
科学领域:
- 肌肉再生和神经生物学
- 骨肌肉生理学 骨肌肉生理学
- 对创伤伤害的药理干预措施.
背景情况:
- 大量的肌肉损失 (VML) 损伤会损害骨肌肉的再生和功能.
- 二次性消毒和神经营养信号的升高 (神经调节素-1) 是VML的后续.
- 针对神经营养信号传递是VML的潜在治疗策略.
研究的目的:
- 在VML损伤后通过ErbB2抑制 (Herceptin) 药理上降低神经营养信号的疗效.
- 评估是否将ErbB2抑制与切碎的肌肉移植结合起来可以协同改善功能恢复.
- 评估ErbB2抑制对神经肌肉结 (NMJ) 内置和VML后形态的影响.
主要方法:
- 使用了手术诱导的小腿前部VML损伤的成年雄性路易斯大鼠.
- 动物被随机分为四组:未经治疗的VML,VML + Herceptin,VML + 肌肉移植和VML + 肌肉移植 + Herceptin.
- 赫塞普丁在手术时以8mg/kg的内注射,并在手术后每周三次,持续48天.
- 神经肌肉结 (NMJ) 内置和体内最大扭矩被评估为终端.
主要成果:
- 在VML受伤后,ErbB2抑制完全恢复了正常的NMJ内和形态.
- 结合肌肉移植和Herceptin的联合治疗改善了de novo肌纤维的内化.
- 通过最大扭矩测量骨肌功能,单独或与肌肉移植结合的ErbB2抑制并没有改善.
结论:
- 药理上的ErbB2抑制证明了在VML损伤后改善肌肉内置的潜力.
- 虽然ErbB2抑制增强了NMJ特征,但它不能单独地恢复VML后的骨肌功能.
- 需要进一步的研究来优化ErbB2抑制策略,以将改善的内化转化为VML患者的功能恢复.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
648
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
648
Skeletal Muscle Relaxants: Therapeutic Uses
457
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
457
Depolarizing Blockers: Mechanism of Action
1.1K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.1K
Relaxation of Skeletal Muscles
3.0K
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
3.0K


